Göbel, A., Kuhlmann, J. D., Link, T., Wimberger, P., Link-Rachner, C., Thiele, S., . . . Rachner, T. D. (2019). Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients. J Bone Oncol.
Παραπομπή Chicago StyleGöbel, Andy, et al. "Plasma Levels of Semaphorin 4D Are Decreased By Adjuvant Tamoxifen but Not Aromatase Inhibitor Therapy in Breast Cancer Patients." J Bone Oncol 2019.
Παραπομπή MLAGöbel, Andy, et al. "Plasma Levels of Semaphorin 4D Are Decreased By Adjuvant Tamoxifen but Not Aromatase Inhibitor Therapy in Breast Cancer Patients." J Bone Oncol 2019.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.